The National Institute for Health and Care Research (NIHR) Delivery Network plays a vital role in advancing research across the NHS, including primary care settings. Click here to find out more.

The James Lind Alliance is a non-profit making initative that brings together patients and clinicians to identify and establish key research priorities, particularly in the area of cardiovascular disease. Full details can be found on there website here. 

These are several key publications that highlight the need to increase the number of clinical academics, particularly within primary care. Take a look at the below: 

• The Academy of Medical Science - Building clinical academic capacity and the allocation of resources across academic specialties
• Medical Research Council - Clinical researchers in the UK: reversing the decline

The NIHR Research Support Service (RSS) is dedicated to helping researchers design impactful studies and apply for funding to bring their projects to life. Their website provides support on how to develop applications for national, peer-reviewed research programmes. For further information, please click here. 

Key funders supporting cardiovascular research include the National Institute for Health and Care Research and the British Heart Foundation. Full details about what they fund can be found on their website. 

The NIHR Academy offers funding opportunities to support primary care team members across disciplines to conduct essential research. It also provides training and support to health and care researchers at all stages of their careers. 

The Primary Care Cardiovascular Society (PCCS) invites you to take part in a short survey on lipid management for secondary prevention patients. Your insights will help us better understand current practice and the challenges healthcare professionals face in achieving lipid targets.

The survey should take just a few minutes to complete and covers key topics such as:

• Current lipid targets in secondary prevention
• Use of combination therapies
• Barriers to prescribing and patient adherence

Your feedback is invaluable in shaping future resources and support for primary care teams.

Click here to take the survey

The BCS Working Party for Ischaemic Heart Disease (IHD) would hugely appreciate responses to a survey of Prescriber Preferences for Clopidogrel or Aspirin Monotherapy. This brief survey explores the preferences for clopidogrel or aspirin monotherapy for long-term secondary prevention of cardiovascular events and the feasibility of a clinical trial.

If you would be happy to take part, please see further info and link to the survey: A Survey of Prescriber Preferences for Clopidogrel or Aspirin Monotherapy

It should only take a couple of minutes to complete and your input would be appreciated.